Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dandan Yu

Showing results (261-270 of 300) with videos related to

Pageof 30
Sort By:
Oncogene|July 27, 2021
Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolismYu Zhang, Qian Yan, Lanqi Gong, et al.
International Immunopharmacology|December 29, 2023
A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatoryHui Zhang, Ke Hu, Yumeng Lu, et al.
Archives of Biochemistry and Biophysics|September 30, 2023
Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myelomaShushan Guo, Zhijian Xu, Qilin Feng, et al.
International Journal of Oncology|June 15, 2018
Dihydrocelastrol exerts potent antitumor activity in mantle cell lymphoma cells via dual inhibition of mTORC1 and mTORC2Yongsheng Xie, Bo Li, Wenxuan Bu, et al.
Translational Oncology|November 15, 2025
Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in multiple myelomaLi Xu, Hui Zhang, Kai Wang, et al.
Biomaterials|September 20, 2020
Targeted galectin-7 inhibition with ultrasound microbubble targeted gene therapy as a sole therapy to prevent acute rejection following heart transplantation in a Rodent modelZhuo Wang, Shuangquan Jiang, Shouqiang Li, et al.
Journal for Immunotherapy of Cancer|January 3, 2023
Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradationBiying Zhang, Jiao Li, Qingling Hua, et al.
Cancer Letters|February 12, 2018
Dual inhibition of mTORC1/2 by DCZ0358 induces cytotoxicity in multiple myeloma and overcomes the protective effect of the bone marrow microenvironmentLu Gao, Bo Li, Guang Yang, et al.
Oncotarget|August 25, 2016
Generation of TALEN-mediated FH knockout rat modelDandan Yu, Yali Zhong, Xiaoran Li, et al.
Clinical and Experimental Medicine|July 7, 2024
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosisAnqi Zhang, Ting Sun, Dandan Yu, et al.
Pageof 30

Showing results (261-270 of 300) with videos related to

Sort By:
Pageof 30
Oncogene|July 27, 2021
Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolismYu Zhang, Qian Yan, Lanqi Gong, et al.
International Immunopharmacology|December 29, 2023
A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatoryHui Zhang, Ke Hu, Yumeng Lu, et al.
Archives of Biochemistry and Biophysics|September 30, 2023
Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myelomaShushan Guo, Zhijian Xu, Qilin Feng, et al.
International Journal of Oncology|June 15, 2018
Dihydrocelastrol exerts potent antitumor activity in mantle cell lymphoma cells via dual inhibition of mTORC1 and mTORC2Yongsheng Xie, Bo Li, Wenxuan Bu, et al.
Translational Oncology|November 15, 2025
Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in multiple myelomaLi Xu, Hui Zhang, Kai Wang, et al.
Biomaterials|September 20, 2020
Targeted galectin-7 inhibition with ultrasound microbubble targeted gene therapy as a sole therapy to prevent acute rejection following heart transplantation in a Rodent modelZhuo Wang, Shuangquan Jiang, Shouqiang Li, et al.
Journal for Immunotherapy of Cancer|January 3, 2023
Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradationBiying Zhang, Jiao Li, Qingling Hua, et al.
Cancer Letters|February 12, 2018
Dual inhibition of mTORC1/2 by DCZ0358 induces cytotoxicity in multiple myeloma and overcomes the protective effect of the bone marrow microenvironmentLu Gao, Bo Li, Guang Yang, et al.
Oncotarget|August 25, 2016
Generation of TALEN-mediated FH knockout rat modelDandan Yu, Yali Zhong, Xiaoran Li, et al.
Clinical and Experimental Medicine|July 7, 2024
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosisAnqi Zhang, Ting Sun, Dandan Yu, et al.
Pageof 30